Johnson & Johnson (NYSE: JNJ) is a healthcare giant that sells over-the-counter products, pharmaceuticals, and medical devices. Its diversification makes it a core holding for many investors, including income investors who love its …
NEW YORK – The U.S. stock market is down at midday, hit by a combination of lower earnings at Johnson &
I won't sell a stock for having a bad quarter or because I don't like ... and previously handled the marketing for Johnson & Johnson's (NYSE:JNJ) skin care division. That said, after this quarter, the company is dangerously close to blowing …
OMAHA, Nebraska (Reuters) - Warren Buffett criticized Johnson & Johnson, a large investment for his company Berkshire Hathaway Inc, for using too much of its own stock in a planned $21.7 billion takeover of Swiss medical …
The board of Johnson & Johnson has authorized the repurchase of up to $500 million of its common shares for general corporate use. J.& J. said the buyback would be through open-market transactions from "time to time" through …
Johnson & Johnson slumped 4.3 percent and Procter & Gamble lost 3.1 ... 9:35 a.m. Gains in technology and consumer-focused companies are sending stock indexes mostly higher in early trading on Wall Street. Netflix soared 11 percent …
AbbVie is one drug stock that risk-tolerant investors should keep an eye on in 2016, due to its strong dividend payout and full-year 2016 EPS guidance. Johnson & Johnson (NYSE: JNJ) is another major drug manufacturer and S&P 500 …
Healthcare conglomerate Johnson & Johnson might be a $280-plus billion dollar company, but it's certainly not growing like one as evidenced by the company's robust growth reported in the second quarter. For the quarter, Johnson &